Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -22.03
- Piotroski Score 4.00
- Grade Neutral
- Symbol (AFIB)
- Company Acutus Medical, Inc.
- Price $0.06
- Changes Percentage (-4.76%)
- Change -$0
- Day Low $0.06
- Day High $0.06
- Year High $0.43
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/08/2024
- Fiscal Year End N/A
- Average Stock Price Target $1.50
- High Stock Price Target $1.50
- Low Stock Price Target $1.50
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.33
- Trailing P/E Ratio -0.14
- Forward P/E Ratio -0.14
- P/E Growth -0.14
- Net Income $-81,663,000
Income Statement
Quarterly
Annual
Latest News of AFIB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Olympic medalist Connor Fitzpatrick highlights AFib journey at 2024 MedTech conference
Olympic medalist Connor Fitzpatrick shared his battle with AFib at the 2024 MedTech Conference, emphasizing the rise of the condition among young athletes. Innovations like pulsed-field ablation offer...
By Yahoo! Finance | 3 weeks ago -
Abbott advances two pulsed field ablation studies for AFib treatment
Abbott achieved key milestones in trials for their pulsed field ablation (PFA) technology, with positive results in VOLT-AF study for atrial fibrillation. The innovative VOLT PFA system offers improve...
By Yahoo! Finance | 1 month ago -
Ultrahuman adds AFib detection feature to Ring AIR smart ring
UK company Ultrahuman introduced an AFib detection feature to its Ring AIR smart ring, along with PowerPlugs platform for personalized health tracking. CEO Mohit Kumar highlighted the importance of cu...
By Yahoo! Finance | 4 months ago
